Several FABP4 inhibitors have been shown to be effective in alleviating chronic inflammatory disorders, including insulin resistance, atherosclerosis, nonalcoholic fatty liver disease, and osteoarthritis (17, 18, 46). This evidence concerns the gene FABP4 and osteoarthritis.